Streetbeat News

Earnings

MLM

Martin Marietta Materials (MLM) reported Q4 earnings of $4.63 per share, surpassing the $3.99 estimate, marking a 53.82% increase from last year. However, their sales of $1.60B fell short of the $1.63B estimate, though it's an 8.47% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 11:58 am

R

Ryder System, Inc. projects its FY24 comparable EPS to be in the range of $11.50-$12.50, compared to the estimated $11.91. The company also expects a total revenue growth of approximately 13%.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 11:57 am

GPN

Global Payments (NYSE:GPN) reported Q4 adjusted earnings of $2.65 per share, surpassing the $2.64 estimate, marking a 9.5% year-over-year increase. Adjusted sales reached $2.19B, exceeding the $2.18B estimate, up 8.11% from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 11:57 am

R

Ryder System (NYSE:R) reported Q4 2023 earnings of $2.95 per share, surpassing the $2.73 estimate, with sales of $3.02B also beating the $2.98B estimate. This represents a 2.10% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 11:56 am

BXMT

Blackstone Mortgage Trust (BXMT) reported Q4 2023 distributable EPS of $0.69, surpassing the analyst consensus estimate of $0.62 by 11.29%.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 11:54 am

BMY

GILD

PFE

Wall Street's most accurate analysts have provided updates on three high-yield dividend health care stocks: Pfizer Inc. (PFE), Bristol-Myers Squibb Company (BMY), and Gilead Sciences, Inc. (GILD). Pfizer's dividend yield is 6.23%, with mixed analyst ratings and a recent expansion of its agreement with Saama for AI-driven data solutions. Bristol-Myers Squibb, with a 4.93% dividend yield, received a downgrade and a price target cut but reported a revenue increase in Q4. Gilead Sciences, offering a 4.19% dividend yield, also saw price target adjustments and recently announced the acquisition of CymaBay Therapeutics.

Portfolio Pulse from Avi Kapoor

February 14, 2024 | 11:54 am

STNG

Scorpio Tankers (NYSE:STNG) reported Q4 adjusted EPS of $2.75, surpassing the $2.63 estimate, with sales of $336.31M also beating the $334.98M estimate. However, these figures represent a significant decrease from the same period last year, with earnings down 35.14% and sales down 31.88%.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 11:49 am

CRWS

Crown Crafts reported a 30.77% increase in Q3 EPS to $0.17 from $0.13 YoY, and a 25.24% increase in sales to $23.80M from $19.00M YoY.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 11:48 am

SAH

Sonic Automotive (NYSE:SAH) reported Q4 adjusted EPS of $1.63, missing the $1.87 estimate, and sales of $3.58B, below the $3.62B estimate. This represents a 37.55% decrease in EPS and a 0.17% decrease in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 11:47 am

EAF

GrafTech reported a decrease in Q4 sales volume by 13% year-over-year to 24.1 thousand metric tons, and a production volume decrease of 17% year-over-year to 24.4 thousand metric tons.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 11:44 am